The detection of early enhancement image of pericholecystic liver using contrast enhanced ultrasonography (parametric imaging and Time Intencity Curve) in the patients of acute choplecystitis.

The detection of early enhancement image of pericholecystic liver using contrast enhanced ultrasonography (parametric imaging and Time Intencity Curve) in the patients of acute choplecystitis. - The detection of early enhancement image of pericholecystic liver using contrast enhanced ultrasonography in the patients of acute choplecystitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024393

Enrollment

Registered

2016-10-13

Start date

2013-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute cholecystitis (control

Interventions

Acute cholecystitis group US examinations were performed with a diagnostic ultrasound system (TUS-A500

Toshiba, Tokyo, Japan) Sonazoid was injected intravenously (bolus, 0.015 mL/kg) followed by 10 mL of saline within 10 s. Non cholecystitis group US examinations were performed with a dia

Toshiba, Tokyo, Japan) Sonazoid was injected intravenously (bolus, 0.015 mL/kg) followed by 10 mL of saline within 10 s.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute cholecystitis Group The diagnosis of Acute cholecystitis was based on the TG13 (Updated Tokyo Guide lines) criteria. Non-cholecystitis Group They undergo CEUS to search for metastatic liver tumors that could not be detected by gray-scale US.

Exclusion criteria

Exclusion criteria: Exclusion criteria a focal spared area in the LPA to the gallbladder portal vein embolism

Design outcomes

Primary

Measure	Time frame
Sensitibity, Specificity	—

Countries

Japan

Contacts

Public ContactHata Jiro

Kawasaki Medical School Departments of Clinical Pathology and Laboratory Medicine

ultrajiro@nifty.com086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026